18FDG SUV in the primary tumor and lymph node metastases is not predictive for development of distant metastases in high risk head and neck cancer patients

Oral Oncology
Jasmijn MeeuwisRemco de Bree

Abstract

Pretreatment screening on distant metastases is particularly useful in head and neck squamous cell carcinoma (HNSCC) patients with high risk factors. In a retrospective study of 88 patients with previously identified clinical high risk factors the predictive value of standardized uptake value (SUV) of 18F-fluorodeoxyglucose (FDG) in the primary tumor and in the lymph node metastases for the development of distant metastases was examined. Different SUVs corrected for plasma glucose levels and body mass index were calculated and analysed in different patient groups: all patients (n=88), patients with a follow up >6months (n=73), not previously treated patients (n=51) and not previously treated patients with a follow up >6months (n=40). Twenty-four of the 88 (27%) high risk HNSCC patients were diagnosed with distant metastases during screening and follow up. No correlation was found between different SUVs of the primary tumor and lymph nodes metastases and the development of distant metastases. SUVs of primary tumor and lymph node on FDG-PET are not predictive for distant metastases in a (selected) group of patients with already high risk factors for distant metastases.

References

Mar 16, 2000·The Laryngoscope·R de BreeC R Leemans
Jul 28, 2004·International Journal of Radiation Oncology, Biology, Physics·Abdelkarim S AllalPavel Dulguerov
Dec 22, 2004·Archives of Otolaryngology--head & Neck Surgery·David L SchwartzKenneth Krohn
Sep 2, 2005·Head & Neck·Kwok Seng LohJonathan C Irish
Jul 11, 2006·European Journal of Radiology·Redina LjumanovicJonas A Castelijns
May 4, 2007·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Sang Yoon KimSung-Bae Kim
Sep 23, 2008·Oral Oncology·Hidenori SuzukiTsuneo Tamaki
Nov 17, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Ronald BoellaardBernd J Krause
Jul 20, 2010·Head & Neck Oncology·Gregory J KubicekMitchell Machtay
Sep 28, 2010·Head & Neck·David I KupermanDaniel Morgensztern
Dec 22, 2011·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Ronald Boellaard
Dec 16, 2011·International Journal of Radiation Oncology, Biology, Physics·Min YaoMitchell Machtay
Apr 12, 2012·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Elizabeth H DibbleRathan M Subramaniam
Apr 21, 2012·Oral Oncology·Missak HaigentzAlfio Ferlito
Apr 24, 2012·Oral Oncology·Remco de BreeAlfio Ferlito
Apr 24, 2012·Oral Oncology·Robert P TakesAlfio Ferlito

❮ Previous
Next ❯

Citations

Feb 6, 2018·Advances in Therapy·Remco de BreeAlfio Ferlito

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.